Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04145037
Brief Title: Phase 1/2 Lentiviral Vector Gene Therapy - The GuardOne Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease

First Submitted : August 27, 2019
First Submitted that Met QC Criteria : October 28, 2019
First Posted : October 30, 2019

Last Update Submitted that Met QC Criteria : February 14, 2020
Last Update Posted : February 17, 2020